Amid rising viral cases, Bharat Biotech working on H3N2 vaccine

Amid rising cases of H3N2 influenza virus in the country and reports of some deaths too, Hyderabad-based vaccine maker Bharat Biotech, which developed the indigenous Covaxin and intranasal vaccine iNCOVACC, is now working on a vaccine for it, its founder chairman Dr Krishna Ella confirmed on Friday.